Skip to Content

par 867 (Dronabinol 2.5 mg)

Pill imprint par 867 has been identified as Dronabinol 2.5 mg.

Dronabinol is used in the treatment of aids related wasting; post traumatic stress disorder; anorexia; nausea/vomiting, chemotherapy induced and belongs to the drug class miscellaneous antiemetics. Risk cannot be ruled out during pregnancy. Dronabinol 2.5 mg is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Dronabinol 2.5 mg par 867
Dronabinol
Imprint:
par 867
Strength:
2.5 mg
Color:
White
Size:
12.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Miscellaneous antiemetics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
3 - Moderate abuse potential
Manufacturer:
Par Pharmaceutical Inc.
National Drug Code (NDC):
49884-0867
Inactive Ingredients:
FD&C Yellow No. 6
gelatin
glycerin
water
sesame oil
titanium dioxide
FD&C Blue No. 1
FD&C Red No. 40
ferrosoferric oxide
shellac
isopropyl alcohol
butyl alcohol
propylene glycol
ammonia
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0174 Amerisource Health Services

Note: Inactive ingredients may vary.

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide